PLUS1
229.0675
-2.30 (-1.0%)
-2.30 (-1.0%)
Upgrade to Real-Time
Regular Market
| Volume | 21,010 |
|
|||||
| News | - | ||||||
| Day High | 230.96 | Low High |
|||||
| Day Low | 228.24 | ||||||
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Alnylam Pharmaceuticals Inc | ALNY | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
|
|
|---|---|---|---|---|
| -2.30 | -1.0% | 229.0675 | 01:55:43 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 229.81 | 228.24 | 230.96 | 231.37 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 624 | 21,010 | US$ 229.79 | US$ 4,827,899 | - | 117.58 - 242.97 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 01:55:55 | 1 | US$ 228.99 | USD |
Period:
Draw Mode:
Alnylam Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 28.18B | 123.03M | 104.74M | US$ 844.29M | US$ -827.32M | -7.20 | -23.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | -23.82k | 0.30% |
Alnylam Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 10/1/2023 | 08:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 10/1/2023 | 08:06 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) |
| 09/1/2023 | 23:02 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 09/1/2023 | 10:00 | Business Wire | Alnylam Announces Preliminary* Fourth Quarter and Full Year.. |
| 07/1/2023 | 08:17 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 06/1/2023 | 08:00 | Business Wire | Alnylam Announces Updates to its Board of Directors |
| 04/1/2023 | 08:00 | Business Wire | Alnylam to Webcast Presentation at 41st Annual J.P. Morgan.. |
| 22/12/2022 | 00:00 | Business Wire | Alnylam Submits CTA Application for ALN-KHK, an.. |
| 16/12/2022 | 00:00 | Business Wire | Alnylam Announces 2023 Product and Pipeline Goals and.. |
| 09/12/2022 | 08:00 | Business Wire | Alnylam Submits Supplemental New Drug Application (sNDA) to.. |
| 08/12/2022 | 23:00 | Business Wire | Alnylam to Webcast Virtual R&D Day |
| 01/12/2022 | 23:00 | Business Wire | Alnylam Ranks #1 on Boston Globe’s Top Places to Work List.. |
Historical ALNY Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 228.85 | 234.78 | 225.02 | 230.08 | 680,964 | 0.2175 | 0.1% |
| 1 Month | 238.00 | 242.39 | 212.64 | 229.06 | 723,341 | -8.93 | -3.75% |
| 3 Months | 208.74 | 242.97 | 197.22 | 225.56 | 732,742 | 20.33 | 9.74% |
| 6 Months | 141.82 | 242.97 | 138.175 | 214.33 | 964,286 | 87.25 | 61.52% |
| 1 Year | 132.58 | 242.97 | 117.58 | 183.21 | 895,248 | 96.49 | 72.78% |
| 3 Years | 116.72 | 242.97 | 84.97 | 163.65 | 733,570 | 112.35 | 96.25% |
| 5 Years | 131.92 | 242.97 | 60.27 | 133.07 | 770,856 | 97.15 | 73.64% |